Aspaveli®

Active substance pegcetacoplan
Holder Swidish Orphan Biovitrum AB
Status closed
Indication Treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who are anaemic despite treatment with a C5 inhibitor for at least 3 months.
Public documents Approbation
  Information for the patient
  Informed consent
Last update

31/03/2023

 

Last updated on 13/02/2024